MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling

As a prevalent tumor among women, breast cancer is still an incurable disease due to drug resistance. In this study, we report microRNA‐221 to have a significant effect on breast cancer resistance to adriamycin. The microRNA‐221 is elevated in tumor tissue compared with nearby nontumor samples, as w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Yin, Yingchun, Wang, Xinmei, Li, Tangyue, Ren, Qi, Li, Liang, Sun, Xiaoyu, Zhang, Baohua, Wang, Xinyun, Han, Hongmei, He, Yangyang, Cao, Zhen, Sun, Xiaojie, Zhou, Ziqiang
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Cancer Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013069/
https://ncbi.nlm.nih.gov/pubmed/31899608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2817
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars